Tenon Medical Director Stephen Hochschuler Receives 10,732 Shares

What Happened

• Stephen Hochschuler, a director of Tenon Medical, converted 10,732 restricted stock units (RSUs) into 10,732 shares of common stock on July 31, 2026. The conversion is reported as an "exercise/conversion of derivative" (transaction code M) at $0.00 per share, so no cash was paid and no shares were sold.

Key Details

• Transaction date: July 31, 2026; Filing date: August 4, 2026 (filed within the typical Form 4 reporting window).
• Transaction type/code: Conversion of RSUs (M). Two report lines show acquisition of 10,732 shares and disposition of 10,732 derivative units (the RSUs were extinguished upon conversion).
• Price and value: $0.00 per share; total cash paid = $0.
• Shares owned after transaction: Not specified in the provided filing data.
• Footnotes: The 10,732 shares represent conversion of RSUs granted Oct 13, 2025; each RSU equals one contingent right to one common share.
• No sale or open-market purchase occurred — this was a vesting/conversion event, not a trade.

Context

• Converting vested RSUs into common shares is a routine insider event and does not by itself signal a buy or sell decision in the market. Because no shares were sold, there is no immediate change to market exposure from this filing alone.